BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25421691)

  • 21. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
    Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
    Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic alternations and cancer chemotherapy response.
    Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand up 2 cancer study.
    Azad NS; El-Khoueiry A; Yin J; Oberg AL; Flynn P; Adkins D; Sharma A; Weisenberger DJ; Brown T; Medvari P; Jones PA; Easwaran H; Kamel I; Bahary N; Kim G; Picus J; Pitot HC; Erlichman C; Donehower R; Shen H; Laird PW; Piekarz R; Baylin S; Ahuja N
    Oncotarget; 2017 May; 8(21):35326-35338. PubMed ID: 28186961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The epigenetic alteration and the effect of HDAC inhibitors in multiple myeloma].
    Terui Y
    Nihon Rinsho; 2015 Jan; 73(1):124-9. PubMed ID: 25626317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic changes in colorectal cancer.
    Jia Y; Guo M
    Chin J Cancer; 2013 Jan; 32(1):21-30. PubMed ID: 22059907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-dependent clinical prognostic value of histone modifications in colorectal cancer.
    Goossens-Beumer IJ; Benard A; van Hoesel AQ; Zeestraten EC; Putter H; Böhringer S; Liefers GJ; Morreau H; van de Velde CJ; Kuppen PJ
    Transl Res; 2015 May; 165(5):578-88. PubMed ID: 25488396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer.
    Lu R; Wang X; Sun DF; Tian XQ; Zhao SL; Chen YX; Fang JY
    Epigenetics; 2008 Nov; 3(6):330-5. PubMed ID: 19098451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia mimetic deferoxamine influences the expression of histone acetylation- and DNA methylation-associated genes in osteoblasts.
    Vrtačnik P; Marc J; Ostanek B
    Connect Tissue Res; 2015 Jun; 56(3):228-35. PubMed ID: 25674819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.
    Hodjat M; Rahmani S; Khan F; Niaz K; Navaei-Nigjeh M; Mohammadi Nejad S; Abdollahi M
    Arch Toxicol; 2017 Jul; 91(7):2577-2597. PubMed ID: 28516248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation and colorectal cancer.
    Matsubara N
    Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic effects of metformin: From molecular mechanisms to clinical implications.
    Bridgeman SC; Ellison GC; Melton PE; Newsholme P; Mamotte CDS
    Diabetes Obes Metab; 2018 Jul; 20(7):1553-1562. PubMed ID: 29457866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.